Venetoclax with Induction & Consolidation
A Phase II Randomized Clinical Trial of Venetoclax Combined With FLAG IDA Induction and Consolidation Compared to Standard of Care for Newly Diagnosed Patients With Acute Myeloid Leukemia
Arms / Cohorts
Experimental:Arm 1: Fludarabine, Cytarabine, Idarubicin, Venetoclax
Accepting patients
Active Comparator:Arm 2: Cytarabine, Daunorubicin
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.